Cargando…
Clinical significance of plasma free DNA in patients with non-small cell lung cancer
OBJECTIVES: Plasma free DNA is a promising new tumor biomarker, which may have applications in clinical diagnosis and treatment of non-small cell lung cancer (NSCLC). METHODS: Plasma free DNA was collected from 120 healthy controls and 116 patients with NSCLC before and after treatment. RESULTS: The...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6862902/ https://www.ncbi.nlm.nih.gov/pubmed/31547735 http://dx.doi.org/10.1177/0300060519872046 |